Possibilities of influencing the hepatotoxicity of chemotherapeutics by the use of silymarin
Barton, P.; Krejcí, V.; Blazek, M.
Casopis Lekaru Ceskych 124(6): 173-175
1985
ISSN/ISBN: 0008-7335 PMID: 3971405 Document Number: 257554
Document emailed within 1 workday
Related Documents
Eichenwald, H.F.; Schmid, F. 1977: Antibiotics and chemotherapeutics. 3. Streptomycin, kanamycin, tobramycin (nebcin), sisomycin, amikacin, netilmicin; polymyxine, spectinomycin, narrow-spectrum antibiotics, local antibiotics; chemotherapeutics: antituberculosis agents (isoniazide, rifampicin Fortschritte der Medizin 95(39): 2359-2363Vanĕk, I.; Buda, J. 1973: Possibilities of prevention and early influencing of postoperative pancreatitis Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 52(9): 625-629
Breddin, K. 1984: Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(10): 234-241
Rakická, E.; Stolz, I.; Geizerová, H.; Widimský, J.; Matousová, M.; Hejl, Z.; Hurych, J.; Petrzilková, Z.; Pistulková, H.; Kaucká, J. 1982: Obstacles and possibilities of influencing physical activity within the framework of primary prevention of ischemic coronary disease Vnitrni Lekarstvi 28(11): 1102-1108
Tabarka, K.; Buzek, B.; Tabarková, H.; Mikulík, J. 1981: Possibilities of influencing impotentia coeundi with physiatric therapy. Correlation between therapeutical results and patient's personality and anxiety level monitoring Casopis Lekaru Ceskych 120(51): 1557-1560
Van Turnhout, J. 1997: Chemotherapeutics Tijdschrift Voor Diergeneeskunde 122(6): 177
Mitsuya, H. 1991: Inhibitors of HIV-1 reverse transcriptase and protease as chemotherapeutics for AIDS Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2062-2069
Golbs, S.; Horn, R. 1989: The absorption behavior of chemotherapeutics after intrauterine administration in cattle Archiv für Experimentelle Veterinarmedizin 43(4): 533-539
Benda, L.; Zenz, W. 1973: Silymarin in liver cirrhosis Wiener Medizinische Wochenschrift 123(3): 512-516
Palattella, G.; De Francesco, G.; Palattella, P.; Mangani, F. 1985: Chemotherapy in dental surgery: comparative study of chemotherapeutics in current use Dental Cadmos 53(8): 69-70; 73 77-79
Ehlers, D. 1989: Side effects of the trypanocidal chemotherapeutics trypan blue and suramin Angewandte Parasitologie 30(3): 189-192
Müscher, C.H. 1972: Silymarin in chronic liver diseases Therapie der Gegenwart 111(12): 1768-1770 Passim
Zaidi, S.Nuzhat.Fatima.; Mahboob, T. 2017: Prevention of liver cirrhosis by Silymarin Pakistan Journal of Pharmaceutical Sciences 30(4): 1203-1211
Nicodemus, T.; Văduva, D.B.; Adămuţ, M.; Linţa, M.; Velimirovici, D.; Orb, C.E.; Păun, M.; Moldovan, R. 2005: Monitoring of resistance to chemotherapeutics of enterobacteria strains isolated from urocultures from out-patients Bacteriologia Virusologia Parazitologia Epidemiologia 50(1-2): 49-57
Donckaster, R.; Atias, A.; Faiguenbaum, J.; Jarpa, A.; Sapunar, J.; Cuello, E. 1964: Chronic Intestinal Amebiasis. Therapeutic Trial of Antibiotics, Chemotherapeutics and Placebos Boletin Chileno de Parasitologia 19: 46-54
Young, S.D. 2001: Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics Current Opinion in Drug Discovery and Development 4(4): 402-410
Schmähl, D.; Osswald, H. 1970: Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents Arzneimittel-Forschung 20(10): 1461-1467
Esposito, S.; Galante, D.; Pennucci, C.; Barba, D.; Limauro, D.; Scioli, C. 1984: Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(3): 196-199
Wagner, H.; Diesel, P.; Seitz, M. 1974: The chemistry and analysis of silymarin from Silybum marianum Gaertn Arzneimittel-Forschung 24(4): 466-471
Matveev, A.V.; Koniaeva, E.I. 2011: The use of silymarin in patients with toxic and viral liver diseases Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 84-90